Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute My... 
No comment yet.
Sign up to comment
Scoop.it!
Cytomedix, Inc. (CMXI) (the “Company”), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies, announces the initiation of a Phase I clinical study with ...
|
Scoop.it!
From
trialx
Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy (#clinicaltrials Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy: BT-062, an ant...)...
Scoop.it!
From
trialx
Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results (#clinicaltrials Elotuzumab, CS1 Directed Antibody Therapy For Multiple Myeloma: Clinical Trial Results: Monoclon...)...
|
